Published in EMBO J on February 11, 2010
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst (2012) 2.79
Therapeutic strategies for targeting ras proteins. Genes Cancer (2011) 2.45
Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene (2010) 1.68
Legionella pneumophila strain 130b possesses a unique combination of type IV secretion systems and novel Dot/Icm secretion system effector proteins. J Bacteriol (2010) 1.64
Functional specificity of ras isoforms: so similar but so different. Genes Cancer (2011) 1.30
KRAS as a Therapeutic Target. Clin Cancer Res (2015) 1.11
RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize? Clin Cancer Res (2015) 1.08
Role of mitofusin 2 (Mfn2) in controlling cellular proliferation. FASEB J (2013) 1.03
Targeting the RAS oncogene. Expert Opin Ther Targets (2013) 1.02
Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway. Proc Natl Acad Sci U S A (2014) 0.99
Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1. Mol Cancer Res (2011) 0.98
Genetic analysis of Ras genes in epidermal development and tumorigenesis. Small GTPases (2013) 0.95
Development of siRNA payloads to target KRAS-mutant cancer. Cancer Discov (2014) 0.95
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design. Nat Rev Drug Discov (2016) 0.88
The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer. Acta Pharmacol Sin (2015) 0.87
Activity of PLCε contributes to chemotaxis of fibroblasts towards PDGF. J Cell Sci (2012) 0.83
Activated Ras protein accelerates cell cycle progression to perturb Madin-Darby canine kidney cystogenesis. J Biol Chem (2012) 0.83
RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane. J Biol Chem (2012) 0.83
Depletion of K-Ras promotes proteasome degradation of survivin. Cell Cycle (2013) 0.82
H-ras distribution and signaling in plasma membrane microdomains are regulated by acylation and deacylation events. Mol Cell Biol (2015) 0.82
Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA. Oncotarget (2015) 0.82
The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development. Mol Biol Cell (2012) 0.81
MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation. PLoS One (2014) 0.81
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling. Front Physiol (2012) 0.80
Reversible, interrelated mRNA and miRNA expression patterns in the transcriptome of Rasless fibroblasts: functional and mechanistic implications. BMC Genomics (2013) 0.80
K-Ras protein as a drug target. J Mol Med (Berl) (2016) 0.80
Combination Therapies to Inhibit the RAF/MEK/ERK Pathway in Melanoma: We are not Done Yet. Front Oncol (2015) 0.80
Interaction of Ras with p110γ is required for thymic β-selection in the mouse. J Immunol (2011) 0.80
Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers. PLoS One (2015) 0.80
What links BRAF to the heart function? new insights from the cardiotoxicity of BRAF inhibitors in cancer treatment. Oncotarget (2015) 0.79
KRAS Engages AGO2 to Enhance Cellular Transformation. Cell Rep (2016) 0.79
ERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cells. Neoplasia (2013) 0.79
Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival. Mol Cell Biol (2013) 0.78
Activated N-Ras signaling regulates arterial-venous specification in zebrafish. J Hematol Oncol (2013) 0.78
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS. Nature (2017) 0.76
A mouse model to identify cooperating signaling pathways in cancer. Nat Methods (2012) 0.76
Sos1 disruption impairs cellular proliferation and viability through an increase in mitochondrial oxidative stress in primary MEFs. Oncogene (2016) 0.75
Context-Dependent Effects of Amplified MAPK Signaling during Lung Adenocarcinoma Initiation and Progression. Cell Rep (2017) 0.75
A New View of Pathway-Driven Drug Resistance in Tumor Proliferation. Trends Pharmacol Sci (2017) 0.75
SIRT2 deletion enhances KRAS-induced tumorigenesis in vivo by regulating K147 acetylation status. Oncotarget (2016) 0.75
Ras and p53: An unsuspected liaison. Mol Cell Oncol (2015) 0.75
SUMO wrestling with Ras. Small GTPases (2016) 0.75
A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation. J Biol Chem (2017) 0.75
Bisperoxovandium (pyridin-2-squaramide) targets both PTEN and ERK1/2 to confer neuroprotection. Br J Pharmacol (2017) 0.75
Ras in epidermal proliferation. Oncotarget (2014) 0.75
Feedback activation of neurofibromin terminates growth factor-induced Ras activation. Cell Commun Signal (2016) 0.75
RAS Proteins and Their Regulators in Human Disease. Cell (2017) 0.75
Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma. Genes Dev (2017) 0.75
Coordinating ERK signaling via the molecular scaffold Kinase Suppressor of Ras. F1000Res (2017) 0.75
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell (1995) 21.15
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet (2006) 17.19
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev (1998) 12.55
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene (2007) 11.85
The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J (2000) 9.51
RAS oncogenes: the first 30 years. Nat Rev Cancer (2003) 8.61
The RAF proteins take centre stage. Nat Rev Mol Cell Biol (2004) 8.04
Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell (2005) 7.87
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer (2006) 7.53
Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol (1988) 7.06
Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell (1997) 6.55
Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell (2007) 6.44
Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature (1985) 6.41
Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature (1994) 6.16
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev (1998) 5.60
Multiple Ras functions can contribute to mammalian cell transformation. Cell (1995) 5.24
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell (2003) 5.17
Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev (1998) 5.14
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol (1995) 4.78
Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell (2004) 4.39
K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev (1997) 4.24
Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science (1999) 3.85
Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature (2003) 3.08
Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol (1997) 2.99
The role of erk1 and erk2 in multiple stages of T cell development. Immunity (2005) 2.96
The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta (2007) 2.82
Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol (2001) 2.60
K-ras is essential for the development of the mouse embryo. Oncogene (1997) 2.57
Rap1: a key regulator in cell-cell junction formation. J Cell Sci (2007) 2.44
Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J (2001) 2.32
RAS and RHO GTPases in G1-phase cell-cycle regulation. Nat Rev Mol Cell Biol (2004) 2.24
A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol (1998) 2.20
Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). Cancer Cell (2005) 1.78
Many faces of Ras activation. Biochim Biophys Acta (2008) 1.74
Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J (1997) 1.69
A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol Cell (2006) 1.68
Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J (2001) 1.65
Ral GTPases: corrupting the exocyst in cancer cells. Trends Cell Biol (2005) 1.58
Role of Rho-family proteins in cell adhesion and cancer. Curr Opin Cell Biol (2003) 1.53
Phospholipase C epsilon: linking second messengers and small GTPases. Trends Cell Biol (2006) 1.49
Genetics of RAS signaling in C. elegans. Trends Genet (1998) 1.49
Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. Curr Biol (1996) 1.47
Mek2 is dispensable for mouse growth and development. Mol Cell Biol (2003) 1.44
Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice. EMBO Rep (2005) 1.43
Essential role of B-Raf in ERK activation during extraembryonic development. Proc Natl Acad Sci U S A (2006) 1.28
Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen. Mol Cell Biol (1994) 1.26
Signalling pathways initiated by receptor protein tyrosine kinases in Drosophila. Curr Opin Cell Biol (1994) 1.25
While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable. Mol Cell Biol (2003) 1.24
Analysis of R-Ras signalling pathways. J Cell Sci (2001) 1.20
Ras--a versatile cellular switch. Curr Opin Genet Dev (1998) 1.19
Requirement for Map2k1 (Mek1) in extra-embryonic ectoderm during placentogenesis. Development (2006) 1.14
Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain. Mol Cell Biol (1990) 1.12
RAS signalling is abnormal in a c-raf1 MEK1 double mutant. Mol Cell Biol (1995) 1.10
Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation. Oncogene (1999) 1.07
Compartmentalized signalling: Ras proteins and signalling nanoclusters. FEBS J (2009) 1.06
RIN1 is a breast tumor suppressor gene. Cancer Res (2007) 1.05
Membrane localization of all class I PI 3-kinase isoforms suppresses c-Myc-induced apoptosis in Rat1 fibroblasts via Akt. J Cell Biochem (2005) 1.04
Growth regulation by oncogenes--new insights from model organisms. Curr Opin Genet Dev (2001) 1.03
A-Raf and Raf-1 work together to influence transient ERK phosphorylation and Gl/S cell cycle progression. Oncogene (2005) 0.97
Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins. Oncogene (1999) 0.96
Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer (2009) 11.25
Tumour biology: senescence in premalignant tumours. Nature (2005) 10.15
RAS oncogenes: the first 30 years. Nat Rev Cancer (2003) 8.61
Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell (2007) 8.47
Mammalian cyclin-dependent kinases. Trends Biochem Sci (2005) 5.54
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell (2003) 5.17
Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet (2003) 4.74
Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell (2004) 4.39
Cdk1 is sufficient to drive the mammalian cell cycle. Nature (2007) 4.26
A pericyte origin of spinal cord scar tissue. Science (2011) 4.12
A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma. Cancer Cell (2010) 3.97
The European dimension for the mouse genome mutagenesis program. Nat Genet (2004) 3.84
Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta (2002) 3.77
p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet (2007) 3.30
Three-year outcomes for Medicare beneficiaries who survive intensive care. JAMA (2010) 2.87
Ras in cancer and developmental diseases. Genes Cancer (2011) 2.68
EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. Cancer Cell (2012) 2.59
Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell (2011) 2.56
Cell cycle kinases in cancer. Curr Opin Genet Dev (2007) 2.46
c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma. Cancer Cell (2011) 2.28
A genome-wide association study for myopia and refractive error identifies a susceptibility locus at 15q25. Nat Genet (2010) 2.10
Relationship Between ICU Length of Stay and Long-Term Mortality for Elderly ICU Survivors. Crit Care Med (2016) 2.03
Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A (2011) 2.01
Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat Cell Biol (2009) 1.99
CDK inhibitors in cancer therapy: what is next? Trends Pharmacol Sci (2007) 1.95
Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo. Proc Natl Acad Sci U S A (2006) 1.93
What we have learned about pancreatic cancer from mouse models. Gastroenterology (2012) 1.78
Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). Cancer Cell (2005) 1.78
Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1. Mol Cell Biol (2004) 1.68
Endogenous expression of Hras(G12V) induces developmental defects and neoplasms with copy number imbalances of the oncogene. Proc Natl Acad Sci U S A (2009) 1.67
Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number. Oncogene (2003) 1.62
A catalyst for change: the European cancer Patient's Bill of Rights. Oncologist (2014) 1.55
Genetic predisposition to early recurrence in clinically localized prostate cancer. BJU Int (2012) 1.50
DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS. Nat Struct Mol Biol (2010) 1.49
Concurrent deletion of cyclin E1 and cyclin-dependent kinase 2 in hepatocytes inhibits DNA replication and liver regeneration in mice. Hepatology (2013) 1.48
Use of Intensive Care Services for Medicare Beneficiaries Undergoing Major Surgical Procedures. Anesthesiology (2016) 1.47
Distinct utilization of effectors and biological outcomes resulting from site-specific Ras activation: Ras functions in lipid rafts and Golgi complex are dispensable for proliferation and transformation. Mol Cell Biol (2006) 1.46
Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras. Mol Cell (2011) 1.44
A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition. J Clin Invest (2008) 1.38
Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. Am J Med Genet A (2010) 1.36
Cdk4 promotes adipogenesis through PPARgamma activation. Cell Metab (2005) 1.31
Functional specificity of ras isoforms: so similar but so different. Genes Cancer (2011) 1.30
Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development. Cancer Cell (2005) 1.23
The RasGrf family of mammalian guanine nucleotide exchange factors. Biochim Biophys Acta (2010) 1.22
The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma. J Pathol (2009) 1.22
Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis. EMBO J (2003) 1.21
RasGrf1 deficiency delays aging in mice. Aging (Albany NY) (2011) 1.16
Genetically engineered mouse models of pancreatic adenocarcinoma. Mol Oncol (2013) 1.15
Dimerization of CtIP, a BRCA1- and CtBP-interacting protein, is mediated by an N-terminal coiled-coil motif. J Biol Chem (2004) 1.15
Overall Cdk activity modulates the DNA damage response in mammalian cells. J Cell Biol (2009) 1.14
Prescription of tamoxifen for breast cancer prevention by primary care physicians. Arch Intern Med (2006) 1.12
RasGRF1 disruption causes retinal photoreception defects and associated transcriptomic alterations. J Neurochem (2009) 1.12
Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma. Proc Natl Acad Sci U S A (2013) 1.11
Interest in BRCA1/2 testing in a primary care population. Prev Med (2002) 1.10
Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4. EMBO J (2003) 1.09
Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature aging due to adult stem cell exhaustion. EMBO J (2012) 1.08
Is Cyclin D1-CDK4 kinase a bona fide cancer target? Cancer Cell (2006) 1.08
Risk factors for dementia after critical illness in elderly Medicare beneficiaries. Crit Care (2012) 1.07
RasGRF2, a guanosine nucleotide exchange factor for Ras GTPases, participates in T-cell signaling responses. Mol Cell Biol (2007) 1.07
RASGRF2 regulates alcohol-induced reinforcement by influencing mesolimbic dopamine neuron activity and dopamine release. Proc Natl Acad Sci U S A (2012) 1.06
Mammalian son of sevenless Guanine nucleotide exchange factors: old concepts and new perspectives. Genes Cancer (2011) 1.04
Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice. Cancer Res (2006) 1.03
Targeted disruption of Ras-Grf2 shows its dispensability for mouse growth and development. Mol Cell Biol (2002) 1.03
Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome. Proc Natl Acad Sci U S A (2011) 1.02
Mice thrive without Cdk4 and Cdk2. Mol Oncol (2007) 1.02
Toll-like receptor-4 (TLR4) down-regulates microRNA-107, increasing macrophage adhesion via cyclin-dependent kinase 6. J Biol Chem (2011) 1.01
Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity. Am J Pathol (2002) 0.99
Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice. Kidney Int (2009) 0.97
Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity. Cancer Res (2005) 0.96
Driving the cell cycle to cancer. Adv Exp Med Biol (2003) 0.93
Identification of NOG as a specific breast cancer bone metastasis-supporting gene. J Biol Chem (2012) 0.92
Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation. Am J Pathol (2006) 0.91
Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis. Exp Cell Res (2006) 0.90
H-ras and N-ras are dispensable for T-cell development and activation but critical for protective Th1 immunity. Blood (2011) 0.89
Cdk6-dependent regulation of G(1) length controls adult neurogenesis. Stem Cells (2011) 0.88
Loss of nuclear receptor RXRα in epidermal keratinocytes promotes the formation of Cdk4-activated invasive melanomas. Pigment Cell Melanoma Res (2010) 0.88
Health literacy and breast cancer screening among Mexican American women in South Texas. J Cancer Educ (2012) 0.88
RAS interaction with PI3K p110α is required for tumor-induced angiogenesis. J Clin Invest (2014) 0.87
Postnatal Schwann cell proliferation but not myelination is strictly and uniquely dependent on cyclin-dependent kinase 4 (cdk4). Mol Cell Neurosci (2007) 0.87
H-Ras isoform modulates extracellular matrix synthesis, proliferation, and migration in fibroblasts. Am J Physiol Cell Physiol (2011) 0.87
Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia. Ther Drug Monit (2006) 0.87
CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity. Mol Endocrinol (2002) 0.87
TGF-β1 up-regulates the expression of PDGF-β receptor mRNA and induces a delayed PI3K-, AKT-, and p70(S6K) -dependent proliferative response in activated hepatic stellate cells. Alcohol Clin Exp Res (2013) 0.86
The use of knockout mice reveals a synergistic role of the Vav1 and Rasgrf2 gene deficiencies in lymphomagenesis and metastasis. PLoS One (2009) 0.86
N-ras couples antigen receptor signaling to Eomesodermin and to functional CD8+ T cell memory but not to effector differentiation. J Exp Med (2013) 0.85
Vitamin D receptor B1 and exon 1d: functional and evolutionary analysis. J Steroid Biochem Mol Biol (2004) 0.85